COMMONWEALTH EQUITY SERVICES, LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 68 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$54,000
-20.6%
12,955
+0.6%
0.00%
Q2 2021$68,000
+15.3%
12,880
+0.7%
0.00%
Q1 2021$59,000
+34.1%
12,785
-5.1%
0.00%
Q4 2020$44,000
-2.2%
13,472
-1.6%
0.00%
Q3 2020$45,000
-11.8%
13,692
-9.9%
0.00%
Q2 2020$51,000
-13.6%
15,192
-2.6%
0.00%
Q1 2020$59,000
-47.8%
15,592
-17.0%
0.00%
Q4 2019$113,000
-16.9%
18,792
+3.9%
0.00%
-100.0%
Q3 2019$136,000
-25.3%
18,092
+34.1%
0.00%0.0%
Q2 2019$182,000
+333.3%
13,492
-6.4%
0.00%
Q4 2018$42,00014,4200.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Cruiser Capital Advisors, LLC 36,888$301,0000.15%
Kazazian Asset Management, LLC 18,792$153,0000.14%
Fiduciary Trust Co International of Pennsylvania 202,100$1,649,0000.07%
Engineers Gate Manager LP 66,270$541,0000.04%
THOMPSON DAVIS & CO., INC. 1,534$13,0000.03%
ZEKE CAPITAL ADVISORS, LLC 23,700$193,0000.02%
A.R.T. Advisors, LLC 43,360$353,0000.02%
Cutler Group LLC / CA 20,822$186,0000.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 63,614$519,000,0000.01%
FNY Investment Advisers, LLC 6,000$48,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders